EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Amrita Bhallataka Rasayana (An Ayurvedic Formulation) as a Potential Anticancer Drug: In vitro Evaluation against A-549 Human Cancer Cell Line

Yagnik Mundadiya, Atul Dalvi, Swapnil Chaudhari, Biswajyoti J. Patgiri

Journal of Ayurveda · 2026-07 · 20 (3) · 277-283

DOI: 10.4103/joa.joa_209_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayurveda, online erschienen am 25.09.2026. Verfasst von Yagnik Mundadiya und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mundadiya, Y., Dalvi, A., Chaudhari, S., & Patgiri, B. J. (2026). Amrita Bhallataka Rasayana (An Ayurvedic Formulation) as a Potential Anticancer Drug: In vitro Evaluation against A-549 Human Cancer Cell Line. Journal of Ayurveda, 20(3), 277-283. https://doi.org/10.4103/joa.joa_209_24

Vancouver

Mundadiya Y, Dalvi A, Chaudhari S, Patgiri BJ. Amrita Bhallataka Rasayana (An Ayurvedic Formulation) as a Potential Anticancer Drug: In vitro Evaluation against A-549 Human Cancer Cell Line. Journal of Ayurveda. 2026;20(3):277-283. doi:10.4103/joa.joa_209_24

BibTeX
@article{Mundadiya2026,
  author = {Mundadiya, Yagnik and Dalvi, Atul and Chaudhari, Swapnil and Patgiri, Biswajyoti J.},
  title = {Amrita Bhallataka Rasayana (An Ayurvedic Formulation) as a Potential Anticancer Drug: In vitro Evaluation against A-549 Human Cancer Cell Line},
  journal = {Journal of Ayurveda},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {277--283},
  doi = {10.4103/joa.joa_209_24}
}
Kostenlos starten →